Skin and Soft Tissue Infections

Published on 07/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1132 times

Chapter 38 Skin and Soft Tissue Infections

Cellulitis

Necrotizing skin and soft tissue infections

Infections after animal bites

14 Which organisms are commonly isolated after cat bites?

Pasteurella spp., most commonly, but these infections are usually polymicrobial. Common organisms found in the oral cavity of cats include Bartonella henselae, Moraxella spp., staphylococci, streptococci, and anaerobes. Cats with outdoor exposure can additionally carry Leptospira, Listeria, and Nocardia spp. as well as Francisella tularensis, Streptobacillus moniliformis, Erysipelothrix rhusiopathiae, and Coxiella burnetii, but these organisms are uncommon causes of cat-bite infections. (See Table 38-3.)

Table 38-3 Major Pathogens Isolated from Cat and Dog Bites

  Aerobes Anaerobes
Cat bites Pasteurella spp., Streptococcus spp., Staphylococcus spp., Moraxella spp. Fusobacterium spp., Bacteroides spp., Porphyromonas spp.
Dog bites Pasteurella spp., Streptococcus spp., Staphylococcus spp., Neisseria spp. Fusobacterium spp., Bacteroides spp., Porphyromonas spp., Prevotella spp., Capnocytophaga spp.

Note: Most infections include a mix of aerobes and anaerobes.

Data from Oehler RL, Velez AP, Mizrachi M, et al: Bite-related and septic syndromes caused by cats and dogs. Lancet Infect Dis 9:439-447, 2009.

Surgical site infections

24 What techniques have been shown to reduce the risk of SSI?

Bibliography

1 Anaya D.A., Dellinger E.P. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705–710.

2 Chen I., Kaufisi P., Erdem G. Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii. J Clin Microbiol. 2011;49:439–441.

3 Henry F.P., Purcell E.M., Eadie P.A. The human bite injury: a clinical audit and discussion regarding management of this alcohol-fueled phenomenon. Emerg Med J. 2007;24:455–458.

4 Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–1596.

5 Liu C., Bayer A., Cosgrove S.E., et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:1–38.

6 Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20:247–278.

7 Oehler R.L., Velez A.P., Mizrachi M., et al. Bite-related and septic syndromes caused by cats and dogs. Lancet Infect Dis. 2009;9:439–447.

8 Seaton R.A. Daptomycin: rationale and role in the management of skin and soft tissue infections. J Antimicrob Chemother. 2008;62(suppl 3):iii15–iii23.

9 Sebeny P.J., Riddle M.S., Peterson K. Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. Clin Infect Dis. 2008;47:444–449.

10 Shah S.S., Hall M., Srivastava R., et al. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis. 2009;49:1369–1376.

11 Stevens D.L., Bisno A.L., Chambers H.F., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373–1406.

12 Stevens D.L., Eron L.L. In the clinic: cellulitis and soft-tissue infections. Ann Intern Med. 2009;150:ITC1–16.

13 Talan D.A., Citron D.M., Abrahamian F.M., et al. Bacteriologic analysis of infected dog and cat bites. N Engl J Med. 1999;340:85–92.

14 Tsai Y.H., Wen-Wei Hsu R., Huang K.C., et al. Comparison of necrotizing fasciitis and sepsis caused by Vibrio vulnificus and Staphylococcus aureus. J Bone Joint Surg Am. 2011;93:274–284.

15 Winner J.S., Gentry C.A., Machado L.J., et al. Aztreonam treatment of Pasteurella multocida cellulitis and bacteremia. Ann Pharmacother. 2003;37:392–394.